About CEA / Carcinoembryonic Antigen
Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, but elevated levels have been found in individuals with carcinomas. CEA measurement is mainly used as a tumor marker to identify recurrences after surgical resection. CEA levels may also me raised in some non-neoplastic conditions like ulcerative colitis, pancreatitis and cirrhosis.
Product Specifications Sheets
Scientific articles in which MedixMAB CEA monoclonals have been used
- Bhayana V and Diamandis EP (1989). A double monoclonal time-resolved immunofluorometric assay of carcinoembryonic antigen is serum.Clin. Biochem., 22:433-438.
- Hammarström S et al (1989). Antigenic sites in carcinoembryonic antigen. Cancer Res. 49:4852-4858.